Association of Genetic Variants with Postsurgical Pain: A Systematic Review and Meta-analyses
Open Access
- 29 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 139 (6) , 827-839
Abstract
Background: Postsurgical pain is a key component of surgical recovery. However, the genetic drivers of postsurgical pain remain unclear. A broad review and meta-analyses of variants of interest will help investigators understand the potential effects of genetic variation. Methods: This article is a systematic review of genetic variants associated with postsurgical pain in humans, assessing association with postsurgical pain scores and opioid use in both acute (0 to 48 h postoperatively) and chronic (at least 3 months postoperatively) settings. PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched from 2000 to 2022 for studies using search terms related to genetic variants and postsurgical pain in humans. English-language studies in adult patients examining associations of one or more genetic variants with postsurgical pain were included. The primary outcome was association of genetic variants with either acute or chronic postsurgical pain. Pain was measured by patient-reported pain score or analgesic or opioid consumption. Results: A total of 163 studies were included, evaluating 129 unique genes and 594 unique genetic variants. Many of the reported significant associations fail to be replicated in other studies. Meta-analyses were performed for seven variants for which there was sufficient data (OPRM1 rs1799971; COMT rs4680, rs4818, rs4633, and rs6269; and ABCB1 rs1045642 and rs2032582). Only two variants were associated with small differences in postsurgical pain: OPRM1 rs1799971 (for acute postsurgical opioid use standard mean difference = 0.25; 95% CI, 0.16 to 0.35; cohort size, 8,227; acute postsurgical pain score standard mean difference = 0.20; 95% CI, 0.09 to 0.31; cohort size, 4,619) and COMT rs4680 (chronic postsurgical pain score standard mean difference = 0.26; 95% CI, 0.08 to 0.44; cohort size, 1,726). Conclusions: Despite much published data, only two alleles have a small association with postsurgical pain. Small sample sizes, potential confounding variables, and inconsistent findings underscore the need to examine larger cohorts with consistent outcome measures. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:Keywords
This publication has 74 references indexed in Scilit:
- The correlation between post-operative fentanyl requirements and μ-opioid receptor gene A118G polymorphism in patients undergoing radical gastrectomyExperimental and Therapeutic Medicine, 2013
- Chronic Pain after Lower Abdominal Surgery: Do Catechol-O-Methyl Transferase/Opioid Receptor μ−1 Polymorphisms Contribute?Molecular Pain, 2013
- Genetic contribution of catechol-O-methyltransferase variants in treatment outcome of low back pain: a prospective genetic association studyBMC Musculoskeletal Disorders, 2012
- Genetic Contributions to Clinical Pain and Analgesia: Avoiding Pitfalls in Genetic ResearchThe Journal of Pain, 2009
- Genome-Wide Association Study of Acute Post-Surgical Pain In humansPharmacogenomics, 2009
- Ethnicity and OPRM Variant Independently Predict Pain Perception and Patient-Controlled Analgesia Usage for Post-Operative PainMolecular Pain, 2009
- Evidence for a biopsychosocial influence on shoulder pain: Pain catastrophizing and catechol- O -methyltransferase (COMT) diplotype predict clinical pain ratingsPain, 2008
- Catechol- O -methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptorsPain, 2007
- Somatic and Psychologic Predictors of Long-term Unfavorable Outcome After Surgical InterventionAnnals of Surgery, 2007
- Association of μ‐opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplastyActa Anaesthesiologica Scandinavica, 2006